PHAT - Phathom Pharmaceuticals Non-GAAP EPS of -$1.11 beats by $0.06 revenue of $1.91M misses by $0.23M
2024-05-09 08:05:28 ET
More on Phathom Pharmaceuticals
- Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion
- Phathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Call Transcript
- Phathom a buy at Stifel on new heartburn therapy
- Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
- Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals